Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: Results of a pilot study

Digestive and Liver Disease

Volumn 33, Issue 8, 2001, Pages 693-697

  Andreone, P ^a   Gramenzi, A ^a   Cursaro, C ^a   Biselli, M ^a   Di Giammarino, L ^a   Grazi, G L ^a   Jovine, E ^a   D'Errico A ^a   Galli, S ^a,b   Mazziotti, A ^a   Cavallari, A ^a   Bernardi, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Amantadine; Hepatitis C; Interferon; Liver transplant; Ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; AMANTADINE; CYCLOSPORIN; METHYLPREDNISOLONE; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; STEROID;

ADULT; AGED; ANEMIA; ARTICLE; ASTHENIA; BIOCHEMISTRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPENIA; DIABETES MELLITUS; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEPATITIS C; HISTOPATHOLOGY; HUMAN; INSOMNIA; LETHARGY; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; PARESTHESIA; PILOT STUDY; RECIPIENT; RECURRENT INFECTION; VIROLOGY;

AGED; AMANTADINE; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; RECURRENCE; RIBAVIRIN; TREATMENT OUTCOME;

EID: 17944378087     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(01)80047-5     Document Type: Article

References (14)

1. Liver transplantation in Italy: Current status
2. Recurrent hepatitis C after liver transplantation: Clinical and therapeutical issues
3. Rimantadine for treatment of hepatitis C infection in liver transplant recipients
4. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation
5. Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin
6. Prophylaxis against HCV recurrence after liver transplantation: Effect of interferon and ribavirin combination
7. Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C
8. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
9. Posttransplantation prevention and treatment of recurrent hepatitis C
10. An open trial of IFN alpha recombinant for hepatitis C after liver transplantation
11. Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon
12. Combination of interferon alpha-2b plus ribavirin for recurrent HCV infection after liver transplantation: A randomized controlled study
13. Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation
14. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alpha therapy in chronic hepatitis C